Yahoo Web Search

  1. Momenta (MNTA) Q2 Loss Wider Than Expected, Revenues Miss

    Zacks via Yahoo FinanceAug 05 14:59 PM

    Shares of Momenta Pharmaceuticals Inc. MNTA gained 1.8% on Aug 2 even though the company reported a wider-than-expected loss and missed revenue estimates in the second quarter.

  2. Generic-Drug Giants Accused of Blocking Congressional Probe

    Bloomberg via Yahoo FinanceAug 14 16:16 PM

    The letters renewed a 2014 request for the companies to provide documents related to charges of generic-drug price-fixing. “Not only did your company’s apparent obstruction undermine our investigation ...

  3. The Vanguard Health Care Fund Buys Pfizer, Humana

    GuruFocus.com via Yahoo FinanceAug 05 19:26 PM

    The fund established a new position in Pfizer Inc. (NYSE:PFE), buying 22.29 million shares. The pharmaceutical company has a market cap of $212.67 billion and an enterprise value of $246.56 ...

  4. 9 High-Risk Stocks to Buy for Massive Rewards

    InvestorPlace via Yahoo FinanceAug 07 15:05 PM

    Slow and steady wins the race, as the old adage goes. It also became one of the most indebted companies in the U.S. markets and still is.

  5. Stocks - Wall Street Rebounds Sharply After Monday's Drubbing

    Investing.com via Yahoo FinanceAug 06 17:37 PM

    Both decisions, plus a U.S. announcement that it was branding China a currency manipulator, were clear signals that optimism early in the year that a new trade deal was close was unfounded.

  6. This week, the FDA granted approval to AbbVie’s ABBV oral JAK1-selective inhibitor, upadacitinib, to be marketed by the trade name of Rinvoq. Bayer BAYRY said it is selling its Animal Health ...

  7. Teva Launches Generic Version of Mylan's EpiPen for KIds

    Zacks via Yahoo FinanceAug 21 15:04 PM

    Shares of Teva Pharmaceutical Industries Limited TEVA rose 4.5% on Tuesday after it announced the launch of a generic version of Mylan’s MYL popular EpiPen Jr (epinephrine) auto-injector ...

  1. Ads
    related to Mylan Pharmaceuticals, Inc